Envestnet Asset Management Inc. cut its holdings in Relx Plc (NYSE:RELX - Free Report) by 4.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,820,102 shares of the technology company's stock after selling 78,825 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.10% of Relx worth $91,751,000 at the end of the most recent quarter.
Several other large investors have also modified their holdings of RELX. Sage Mountain Advisors LLC lifted its stake in shares of Relx by 5.1% during the fourth quarter. Sage Mountain Advisors LLC now owns 5,292 shares of the technology company's stock valued at $240,000 after buying an additional 258 shares during the period. DRW Securities LLC raised its stake in Relx by 5.9% during the fourth quarter. DRW Securities LLC now owns 4,652 shares of the technology company's stock worth $211,000 after purchasing an additional 259 shares during the period. Kovitz Investment Group Partners LLC raised its stake in Relx by 3.4% during the fourth quarter. Kovitz Investment Group Partners LLC now owns 8,159 shares of the technology company's stock worth $371,000 after purchasing an additional 267 shares during the period. Ascent Group LLC raised its stake in Relx by 2.0% during the fourth quarter. Ascent Group LLC now owns 14,024 shares of the technology company's stock worth $637,000 after purchasing an additional 277 shares during the period. Finally, Portside Wealth Group LLC raised its stake in Relx by 2.5% during the first quarter. Portside Wealth Group LLC now owns 11,710 shares of the technology company's stock worth $590,000 after purchasing an additional 283 shares during the period. 15.02% of the stock is currently owned by institutional investors and hedge funds.
Relx Trading Up 0.5%
Shares of RELX stock traded up $0.28 during mid-day trading on Monday, reaching $53.90. The company's stock had a trading volume of 1,091,294 shares, compared to its average volume of 749,486. The company's 50 day simple moving average is $53.77 and its 200-day simple moving average is $50.89. Relx Plc has a 12-month low of $43.45 and a 12-month high of $56.33. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46. The firm has a market capitalization of $98.99 billion, a PE ratio of 28.98, a price-to-earnings-growth ratio of 3.23 and a beta of 0.83.
Analyst Upgrades and Downgrades
A number of equities analysts have weighed in on RELX shares. Wall Street Zen downgraded shares of Relx from a "buy" rating to a "hold" rating in a research note on Saturday. Morgan Stanley reaffirmed an "overweight" rating on shares of Relx in a research note on Wednesday, April 16th. Finally, The Goldman Sachs Group started coverage on shares of Relx in a research note on Wednesday, March 26th. They issued a "buy" rating on the stock. One analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Buy".
Check Out Our Latest Stock Analysis on RELX
About Relx
(
Free Report)
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Read More

Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.